Back to Trades
WENTWORTH KORY JAMES
Chief Financial OfficerCIK 0001725663
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 3
- Buy transactions
- 0
- Sell transactions
- 1
- Companies
- 1
- Active
- 2025–2026
WENTWORTH KORY JAMES, Chief Financial Officer, has filed 3 reports across 1 company, totaling $1.0M in disclosed volume. Sales ($97.9K) outpace purchases ($0). Insider sales are common for diversification and should be read in context. All data sourced from SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
3 loaded
| Mar 6 | TRDA Entrada Therapeutics, Inc. | WENTWORTH KORY JAMES | Chief Financial Officer | Sell | $97.9K |
| Mar 3 | TRDA Entrada Therapeutics, Inc. | WENTWORTH KORY JAMES | Chief Financial Officer | Grant | $0 |
| Sep 4 | TRDA Entrada Therapeutics, Inc. | WENTWORTH KORY JAMES | Chief Financial Officer | Other | $0 |
3 filings